🇺🇸 FDA
Patent

US 7264798

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

granted A61KA61K33/243A61K35/765

Quick answer

US patent 7264798 (Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus) held by ONCOLYTICS BIOTECH INC. expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K33/243, A61K35/765, A61K45/06, A61P